4th Quarter - Report

TIBER CREEK GROUP for EMD SERONO, INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to corporate tax

LobbyistCovered position, as disclosed
KRISTEN HARPER —
JEFFREY SHAPIRO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Issues relating to pharmaceutical pricing. Issues relating to drug development. S. 2543 - The Prescription Drug Price Reduction Act. H.R. 3 - Lower Drug Costs Now Act of 2019. H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
ASHLI PALMER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 133 (116th), H.R. 3 (116th), S. 2543 (116th)

Trade (domestic/foreign) TRD

Issues related to supply chain management

LobbyistCovered position, as disclosed
KRISTEN HARPER —
JEFFREY SHAPIRO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Issues relating to Medicare Part D Price Reform. S. 2543 - The Prescription Drug Price Reduction Act. H.R. 3 - Lower Drug Costs Now Act of 2019. H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
ASHLI PALMER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2543 (116th), H.R. 3 (116th), H.R. 133 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.